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Summary  Infective  endocarditis  is  a  serious  disease  that  needs  rapid  diagnosis  and  accurate
risk stratiﬁcation  to  offer  the  best  therapeutic  strategy.  Echocardiography  plays  a  key  role  in
the management  of  the  disease  but  may  be  limited  in  some  clinical  situations.  Moreover,  this
method is  insensitive  for  very  early  detection  of  the  infection  and  assessment  of  therapeutic
response because  it  does  not  provide  imaging  at  the  molecular  and  cellular  levels.  Recently,
several novel  morphological,  molecular  and  hybrid  imaging  modalities  have  been  investigated
in infective  endocarditis  and  offer  new  perspectives  for  better  management  of  the  disease.imaging;
Positron  emission
tomography
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Résumé  L’endocardite  infectieuse  est  une  maladie  grave  qui  nécessite  un  diagnostic  rapide
et une  stratiﬁcation  du  risque  précise  aﬁn  déﬁnir  la  meilleure  stratégie  thérapeutique.
L’échocardiographie  joue  un  rôle  clé  dans  la  prise  en  charge  de  la  maladie  mais  peut  présenter
des limites  dans  certaines  situations  cliniques.  De  plus,  cette  méthode  est  peu  sensible  pour  la
détection très  précoce  de  l’infection  ainsi  que  pour  l’évaluation  de  la  réponse  thérapeutique
car elle  ne  propose  pas  une  imagerie  au  niveau  cellulaire  et  moléculaire.  Récemment,  plusieurs
nouvelles modalités  d’imagerie  morphologique,  moléculaire  et  hybride  ont  été  étudiées  dans  le
domaine de  l’endocardite  infectieuse  et  offrent  de  nouvelles  perspectives  pour  une  meilleure
prise en  charge  de  la  maladie.
©  2012  Elsevier  Masson  SAS.  Tous  droits  réservés.
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forations  and  ruptured  chordae  [15,16]  (Fig.  2).  Thus,Infective endocarditis: from
pathophysiology to imaging
Infective  endocarditis  (IE)  is  a  serious  disease  associated
with  poor  prognosis  despite  improvements  in  medical  and
surgical  therapies  [1—4]. IE  results  in  a  complex  pathogen-
esis  that  involves  many  host-pathogen  interactions  [5—7].
Indeed,  previous  endocardial  lesions  can  lead  to  the  expo-
sure  of  the  underlying  extracellular  matrix  proteins,  local
inﬂammation  and  then  thrombus  formation,  which  is  termed
‘non-bacterial  vegetation’.  In  the  case  of  bacteraemia,
valves  with  pre-existing  sterile  vegetations  or  tissues  with
minimal  lesions  can  be  colonized  because  of  strong  interac-
tions  between  the  bacteria,  platelets  and  endothelial  cells
via  several  bacterial  surface  proteins  or  plasma-bridging
molecules.  This  process  leads  to  the  recruitment  of  circu-
lating  inﬂammatory  cells  and  the  release  of  cytokines  and
procoagulant  factors,  which  contribute  to  the  enlargement
of  vegetations  and  the  protection  of  bacterial  pathogens
from  host  defences.  Ultimately,  valvular  and  perivalvu-
lar  tissues  are  destroyed,  thus  increasing  the  risk  of
valve  dysfunction,  abscess  formation  and  embolization  [8].
Moreover,  in  addition  to  embolic  events,  other  extrac-
ardiac  life-threatening  complications  may  occur,  such  as
infectious  aneurysms  and  intracranial  and  visceral  haemor-
rhages.
Therefore,  early  and  reliable  diagnostic  and  risk  strat-
iﬁcation  strategies  are  critical  to  reduce  delays  to  the
start  of  appropriate  antimicrobial  therapy  and  to  identify
patients  who  require  urgent  valve  surgery.  As  described  in
recent  international  recommendations,  echocardiography  is
a  simple  accurate  method  for  detecting  endocardial  dam-
age  in  IE  and  helping  in  risk  stratiﬁcation  [1,9]. However,
echocardiography  studies  may  be  limited  in  some  clinical
situations  [10—12]  and  this  technique  is  insensitive  for  very
early  detection  of  infection  because  it  does  not  provide  an
imaging  assessment  of  IE  at  the  molecular  and  cellular  lev-
els.  Recently,  other  morphological  and  molecular  imaging
strategies  have  emerged  for  the  detection  of  endocardial
involvement  and  extracardiac  complications.
The  aims  of  this  review  are  to  provide  an  update  on  the
value  of  echocardiography  in  the  management  of  IE,  to  dis-
cuss  the  potential  role  of  other  imaging  techniques  and,
ﬁnally,  to  consider  the  challenges  and  perspectives  in  the
imaging  investigations.
e
a
sorphological imaging of endocardial
amage and its consequences
chocardiography: the main imaging modality
chocardiography  plays  a  key  role  not  only  in  the  diag-
osis  of  IE  but  also  in  the  prognostic  assessment  and
ollow-up  under  therapy  and  during  surgery.  Recently,  rec-
mmendations  for  the  practice  of  echocardiography  in
E  have  been  published,  to  provide  an  update  on  the
alue  and  limitations  of  this  technique  in  IE  and  to
eﬁne  the  optimal  use  of  transthoracic  echocardiogra-
hy  (TTE)  and  transoesophageal  echocardiography  (TEE)
13].
chocardiography  for  the  diagnosis  of  infective
ndocarditis
lthough  IE  may  present  with  several  very  different  initial
ymptoms,  its  diagnosis  usually  relies  on  the  associa-
ion  of  clinical,  microbiological  and  morphological  criteria,
hich  are  included  in  the  modiﬁed  Duke  classiﬁcation
14].  By  detecting  several  forms  of  endocardial  damage,
chocardiography  remains  an  accurate  method  for  pro-
iding  the  major  diagnostic  criteria  of  IE.  Knowledge  of
he  anatomical  features  of  IE  is  fundamental  in  order  to
etter  understand,  analyse  and  describe  the  echocardi-
graphic  ﬁndings  (Table  1).  TTE  is  the  initial  technique
f  choice  for  investigation.  A  normal  scan  in  low-risk
atients  provides  rapid  non-invasive  conﬁrmation  that  the
iagnosis  is  unlikely.  Moreover,  TTE  is  better  than  TEE
or  the  detection  of  anterior  cardiac  abscesses  and  for
aemodynamic  assessment  of  valvular  dysfunction.  Because
f  its  higher  sensitivity  and  speciﬁcity,  TEE  is  recom-
ended  [1,13]  in  cases  of:  negative  TTE  associated  with
igh  clinical  suspicion;  poor  TTE  quality;  presence  of  pros-
hetic  valves  or  intracardiac  device;  and  positive  TTE
Fig.  1).  In  preliminary  studies,  three-dimensional  TEE
rovided  incremental  value  over  two-dimensional  TEE  in
ts  ability  to  accurately  identify  and  localize  vegetations
nd  to  identify  complications  such  as  abscesses,  per-chocardiography  must  be  done  rapidly  and  repeated  once
 week  as  soon  as  it  is  negative  but  the  condition  is
uspected.
54  F.  Thuny  et  al.
Table  1  Anatomical  and  echocardiographic  deﬁnitions.
Surgery/necropsy  Echocardiography
Vegetation Infected  mass  attached  to  an  endocardial
structure  or  on  implanted  intracardiac
material
Oscillating  or  non-oscillating  intracardiac  mass
on  valve  or  other  endocardial  structures,  or  on
implanted  intracardiac  material
Abscess Perivalvular  cavity  with  necrosis  and
purulent  material  not  communicating  with
the  cardiovascular  lumen
Thickened,  non-homogeneous  perivalvular  area
with  echodense  or  echolucent  appearance
Pseudoaneurysm Perivalvular  cavity  communicating  with  the
cardiovascular  lumen
Pulsatile  perivalvular  echo-free  space,  with
colour  Doppler  ﬂow  detected
Perforation  Interruption  of  endocardial  tissue  continuity  Interruption  of  endocardial  tissue  continuity
traversed  by  colour  Doppler  ﬂow
Fistula  Communication  between  two  neighbouring
cavities  through  a  perforation
Colour  Doppler  communication  between  two
neighbouring  cavities  through  a  perforation
Valve  aneurysm  Saccular  outpouching  of  valvular  tissue  Saccular  bulging  of  valvular  tissue
Dehiscence  of  a
prosthetic  valve
Dehiscence  of  the  prosthesis Paravalvular  regurgitation  identiﬁed  by
TTE/TEE,  with  or  without  rocking  motion  of
the  prosthesis
Adapted from Habib et al. [13] with permission.
TEE: transoesophageal echocardiography; TTE: transthoracic echocardiography.
Figure 1. Indications for echocardiography in the diagnosis and
assessment of infective endocarditis. IE: infective endocarditis;
TTE: transthoracic echocardiography; TEE: transoesophageal echo-
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dapted from Habib et al. [1] with permission.
chocardiography  for  risk  stratiﬁcation  and
ollow-up of  infective  endocarditis
n  addition  to  its  role  in  diagnosing  IE,  echocardiography
lso  has  major  prognostic  value  in  IE  in  predicting  death  and
omplications  [17,18].  Heart  failure,  perivalvular  extension
a
m
end embolic  events  represent  the  three  most  frequent  and
evere  complications  of  IE.  Echocardiography  plays  a  key
ole  in  the  management  of  these  complications  by  helping  a
ecision  to  be  made  regarding  valve  surgery  and  its  optimal
iming.
Heart  failure  represents  the  main  indication  for  valve
urgery  in  IE  [19]  and  the  operation  is  usually  indicated  in
n  emerging  (within  24  hours)  or  urgent  (within  a  few  days)
etting  [1,9,20,21]. TEE  allows  identiﬁcation  of  the  mech-
nisms  responsible  for  these  complications,  such  as  acute
alve  regurgitation,  valve  obstruction  or  intracardiac  ﬁstula.
oreover,  TTE  may  provide  criteria  of  poor  haemodynamic
olerance,  such  as  torrential  regurgitation,  elevated  left
nd  right  ﬁlling  pressures,  pulmonary  arterial  pressures  and
entricular  dysfunction.  Even  in  the  absence  of  clinical  con-
estive  signs,  the  presence  of  these  echocardiographic  signs
uggests  the  need  for  valve  surgery  because  the  evolution
o  heart  failure  usually  is  inevitable  [1].
Perivalvular  extensions  are  present  in  around  20%  of  cases
2]  and  indicate  valve  surgery  because  they  expose  the
atient  to  risks  of:  heart  failure  by  the  occurrence  of  ﬁstula
r  prosthetic  valve  dehiscence;  complete  atrioventricular
lock  by  interruption  of  the  cardiac  conduction  system;  and
ersistence  of  the  infection  [22—24]. TEE  is  the  technique
f  choice  for  the  diagnosis  of  perivalvular  extension  and
ts  resulting  complications  but  TTE  seems  better  in  case  of
nterior  abscess  of  the  aortic  annulus  [25].
Embolic  events  are  frequent  and  life-threatening
omplications  of  IE,  which  are  symptomatic  in  around
0—25%  of  cases  [26—29]  and  silent  (only  detected  by  cere-
ral  imaging)  in  almost  50%  of  cases  [26,27].  These  events
re  factors  for  poor  prognosis,  especially  in  case  of  involve-
ent  of  the  cerebral  circulation  bed  [29]. Echocardiography,
specially  TEE,  is  useful  for  the  evaluation  of  embolic  risk
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Figure 2. Mitroaortic infective endocarditis explored by two-dimensional (2D) and three-dimensional (3D) transoesophageal echocardi-
ography (TEE). The 2D TEE (A) shows destruction of the cusps of the aortic valve with vegetations (white arrow) and perforation of the
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ibasal portion of the anterior leaﬂet (red arrow), resulting in severe 
better localization of the mitral perforation thanks to an atrial ‘en 
at  admission,  by  providing  the  maximal  length,  mobility  and
location  of  vegetations.  Indeed,  large  and  highly  mobile
vegetations  are  associated  with  a  higher  risk  of  embolism
[17],  especially  in  the  mitral  position  [30]. This  evaluation
must  be  performed  very  early  in  the  course  of  IE  because
the  risk  of  embolic  events  remains  high  during  the  ﬁrst
week  after  diagnosis  and  initiation  of  antibiotics  [17,31,32].
Therefore,  valve  surgery  should  be  performed  in  an  urgent
setting  when  a  large  vegetation  (>  10  mm)  is  present  fol-
lowing  one  or  more  embolic  episodes.  In  addition,  when
associated  with  other  known  predictors  of  a  complicated
course  (heart  failure,  persistent  infection  under  therapy,
abscess  and  prosthetic  endocarditis),  the  presence  of  a  large
vegetation  (>  10  mm)  indicates  an  earlier  surgical  decision.
Finally,  the  decision  to  operate  in  the  case  of  an  isolated
very  large  vegetation  (>  15  mm)  is  more  difﬁcult  and  must  be
speciﬁc  for  the  individual  patient.  Surgery  may  be  preferred
when  a  valve  repair  seems  possible,  particularly  in  mitral
valve  IE  [1,33]. Nevertheless,  the  prediction  of  embolism
remains  challenging  and  should  take  into  account  other
criteria,  such  as  the  type  of  microorganisms  (Staphylococcus
aureus)  and  conditions  associated  with  a  prothrombogenic
state  (atrial  ﬁbrillation,  diabetes,  etc.).  Recently,  a  ran-
domized  trial  demonstrated  that  early  surgery  in  patients
with  large  vegetations  and  signiﬁcant  valve  dysfunction  sig-
niﬁcantly  reduced  the  composite  endpoint  of  death  from
any  cause  and  embolic  events  by  effectively  decreasing  the
v
p
m
tl regurgitation visualized by colour Doppler (B). The 3D TEE allows
 view (C) and a left ventricle view (D).
isk  of  systemic  embolism  compared  with  conventional  ther-
py  [34]. Although  this  result  is  of  crucial  importance,  it
as  limited  by  the  fact  that  it  was  obtained  in  a  popu-
ation  with  a  very  low  operative  risk.  Thus,  we  now  have
trong  evidence  that  early  surgery  reduces  embolic  risk
ut  we  need  better  risk  stratiﬁcation  in  order  to  eval-
ate  accurately  the  beneﬁt-risk  ratio  of  this  procedure.
ndeed,  for  a  high  embolic  risk  associated  with  a  low  or
ntermediate  predicted  operative  mortality  (computed  by
coring  systems),  the  beneﬁt  of  early  surgery  would  be
reater.
Intraoperative  TEE  is  mandatory  in  patients  operated  on
or  IE;  it  provides  the  surgeon  with  a  ﬁnal  anatomical  evalua-
ion  of  valvular  and  perivalvular  damage,  and  is  particularly
seful  for  assessing  the  immediate  result  of  conservative
urgery,  as  well  as  in  cases  of  complex  perivalvular  repair
35].  Finally,  echocardiography  must  be  used  for  follow-
p  of  patients  with  IE  under  antibiotic  therapy  and  after
urgery,  along  with  clinical  follow-up.  The  number,  type  and
iming  of  repeat  examinations  depend  on  clinical  presen-
ation,  type  of  microorganism  and  initial  echocardiographic
ndings.  After  hospital  discharge,  the  main  complications
nclude  recurrence  of  infection,  heart  failure,  need  for
alve  surgery  and  death.  Thus,  clinical  and  echocardiogra-
hic  periodic  close  follow-up  (at  1,  3,  6  and  12  months)  is
andatory  during  the  ﬁrst  year  after  the  end  of  antibiotic
reatment  [1].
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imitations  of  echocardiography  in  infective
ndocarditis
 negative  echocardiogram  may  be  observed  in  about  15%  of
ases  of  IE.  The  imaging  diagnosis  may  be  particularly  chal-
enging  in  some  cases,  such  as  with  intracardiac  devices,
alvular  prostheses,  the  presence  of  pre-existing  severe
esions  (mitral  valve  prolapse,  degenerative  lesions),  very
mall  vegetations  and  abscesses  or  no  vegetation.  In  addi-
ion,  the  diagnosis  may  be  difﬁcult  at  the  early  stage  of  the
isease.  Conversely,  false  diagnosis  of  IE  may  occur  in  other
ituations:  for  example,  it  may  be  difﬁcult  to  differentiate
etween  vegetations  and  thrombi,  cusp  prolapse,  car-
iac  tumours,  myxomatous  changes,  Lambl’s  excrescences
r  strands.  Thus,  in  some  situations,  the  echocardiogram
emains  negative  or  doubtful,  even  if  it  is  performed  by
xpert  hands  and  after  a  repeat  examination  [12,36].  Inno-
ations  in  the  specialty  of  diagnostic  strategy  have  emerged
o  resolve  these  issues  through  new  imaging  modalities.  Mul-
islice  computed  tomography  (CT)  and  magnetic  resonance
maging  (MRI)  might  help  to  better  identify  both  anatom-
cal  intracardiac  damages  and  extracardiac  complications.
ositron  emission  tomography  (PET)  and  other  molecular
maging  methods  might  provide  imaging  of  the  inﬂamma-
ion  and  infection  at  molecular  level  and  will  be  fused  with
anatomical’  imaging.
ultislice computed tomography
ecent  advances  in  the  temporal  and  spatial  resolution  of
ultislice  CT  scanners  allow  high-resolution  cardiac  imag-
ng.  Currently,  the  major  application  of  multislice  CT  is  in
he  evaluation  of  coronary  artery  disease  but  it  has  been
sed  also  for  heart  valve  disease,  such  as  aortic  stenosis
37]  and,  more  recently,  in  IE  [38—40].
In  a  small  study  of  37  consecutive  patients  with  clini-
ally  suspected  IE,  Feuchtner  et  al.  found  good  results  in
etecting  IE  valvular  and  perivalvular  damage  using  electro-
ardiogram  (ECG)-gated  64-slice  CT  or  dual-source  CT.  The
iagnostic  performance  of  CT  for  the  detection  of  evident
bnormalities  for  IE  compared  with  TEE  was:  sensitivity  97%,
peciﬁcity  88%,  positive  predictive  value  (PPV)  97%  and  neg-
tive  predictive  value  (NPV)  88%  on  a  per-patient  basis.  In
 per  valve-based  analysis,  the  diagnostic  accuracy  for  the
etection  of  vegetations  and  abscesses/pseudoaneurysms
ompared  with  surgery  was:  sensitivity  96%,  speciﬁcity
7%,  PPV  96%,  NPV  97%  and  sensitivity  100%,  speciﬁcity
00%,  PPV  100%,  NPV  100%,  respectively,  without  signiﬁ-
ant  differences  compared  with  TEE.  Although  the  small
eaﬂet  perforations  were  missed,  CT  provided  more  accurate
natomical  information  regarding  the  perivalvular  extent  of
bscesses/pseudoaneurysms  than  TEE  [39]. Gahide  et  al.
ound  similar  results  in  patients  with  aortic  valve  IE  [40].
As  prosthetic  valve  IE  represents  one  of  the  most  difﬁ-
ult  situations  for  echocardiographic  studies,  Fagman  et  al.
ecently  investigated  the  role  of  ECG-gated  64-slice  CT  in
he  diagnosis  of  aortic  prosthetic  valve  IE.  In  27  patients,
he  authors  showed  that  the  strength  of  agreement  between
CG-gated  CT  and  TEE  was  good  for  abscess  and  dehis-
ence,  and  moderate  for  vegetation.  In  comparison  with
ntraoperative  ﬁndings,  CT  detected  three  additional  pseu-
oaneurysms  that  were  unnoticed  by  TEE.  In  two  of  these
t
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ases,  the  pseudoaneurysm  was  located  close  to  the  right
oronary  cusp,  a  location  that  is  difﬁcult  to  investigate  by
EE  [38].
Thus, this  imaging  modality  offers  the  possibility  to
apidly  image  the  heart  and  other  organs  and  thus  to  identify
oth  cardiac  lesions  and  extracardiac  complications,  such
s  embolic  events,  infectious  aneurysms,  haemorrhages  and
eptic  metastases,  which  can  modify  the  therapeutic  strat-
gy  (Fig.  3).  Moreover,  it  provides  an  anatomical  assessment
f  the  coronary  bed,  which  is  important  in  the  preoperative
valuation  [39]. CT  seems  to  be  especially  useful  in  case  of  a
egative  or  inconclusive  echocardiographic  study.  However,
ontrast  products  should  be  used  with  caution  in  patients
ith  renal  failure  or  haemodynamic  instability  because  of
he  risk  of  worsening  renal  impairment  in  combination  with
ntibiotic  nephrotoxicity.  In  some  cases,  the  indications  for
 CT  scan  might  be  limited  to  the  brain  and  its  arteries.
peciﬁc  recommendations  are  needed  to  clearly  deﬁne  the
ppropriate  situations  where  this  modality  should  be  used.
agnetic resonance imaging
lthough  multiple  case  reports  on  the  use  of  MRI  in  identify-
ng  valvular  and  perivalvular  damage  in  patients  with  IE  have
een  published,  this  imaging  modality  seems  to  be  of  most
alue  in  the  identiﬁcation  of  silent  cerebral  complications
26—28,41,42].  The  role  of  cerebral  MRI  in  the  diagnosis
nd  management  of  this  disease  has  been  deﬁned  in  some
tudies,  which  showed  that  systematic  MRI  could  detect
ubclinical  cerebrovascular  complications  in  about  50%  of
atients  [26—28].
In a  single-centre  study,  Duval  et  al.  described  how  the
dentiﬁcation  of  brain  damage  by  cerebral  MRI  modiﬁed
heir  classiﬁcation  and  management  of  130  patients  with
uspected  or  deﬁnite  endocarditis.  In  this  work,  MRI  iden-
iﬁed  cerebral  lesions  in  82%  of  cases.  Solely  on  the  basis
f  these  MRI  results,  and  excluding  microhaemorrhages,  the
iagnostic  classiﬁcation  of  32%  of  the  cases  of  non-deﬁnite
ndocarditis  was  upgraded  to  either  deﬁnite  or  possible.
oreover,  the  therapeutic  plans  were  modiﬁed  for  18%  of
atients,  including  surgical  plan  modiﬁcations  for  14%  [27].
he  same  investigators  analysed  the  beneﬁt  of  the  addition
f  abdominal  MRI  in  these  patients;  they  demonstrated  that
oth  cerebral  and  abdominal  MRI  ﬁndings  affected  diagnosis,
ut  only  cerebral  MRI  affected  clinical  management  plans
43].
MRI  offers  the  advantages  of  a  non-ionizing  imaging
odality  but  is  limited  by  its  lower  spatial  resolution  and
vailability  in  comparison  with  current  CT  scans.
maging of infectious aneurysms
nfectious  (mycotic)  aneurysms  result  from  septic  arte-
ial  embolism  to  the  intraluminal  space  or  vasa  vasorum,
r  from  subsequent  spread  of  infection  through  the  inti-
al  vessels.  Because  of  the  involvement  of  the  muscular
ayer,  infectious  aneurysms  are  actually  pseudoaneurysms
44].  The  intracranial  arteries  are  the  most  frequent  loca-
ion,  with  a  predilection  for  the  distal  branching  points
f  the  middle  cerebral  artery.  The  reported  frequency  of
nfectious  aneurysms  of  2—4%  is  probably  an  underesti-
ation  as  some  are  clinically  silent  [45]. As  the  clinical
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Figure 3. Cardiac and cerebral computed tomography (CT) scan in a patient with a mitroaortic infective endocarditis. This ﬁgure illustrates
that the CT scan allows rapid and accurate assessment of structural cardiac damage and extracardiac complications. The electrocardiogram-
gated cardiac CT scan (A) shows a calciﬁed aortic valve with a large pseudoaneurysm just below the ostium of the left coronary artery (green
arrow) and an ‘aneurysm’ of the mitral valve anterior leaﬂet (red arrow). The cerebral CT scan (B) shows, after contrast injection, the
ebral
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isuspicion of a mycotic (infectious) aneurysm of the right middle cer
reconstruction of the angiography (C,D).
presentation  is  highly  variable  (focal  neurological  deﬁcit,
headache,  confusion,  seizures)  and  the  prognosis  is  poor,
imaging  should  be  performed  to  detect  infectious  aneurysms
in  any  case  of  IE  with  neurological  symptoms  [1].  CT  or  mag-
netic  resonance  (MR)  angiography  may  be  used  to  detect
infectious  aneurysms  with  similar  sensitivity  but  no  recent
large  series  has  been  performed  to  address  this  issue.  A
study  showed  that  the  sensitivities  of  CT  scanning  and  MR
angiography  were  94%  and  86%,  respectively,  for  the  detec-
tion  of  intracranial  non-infectious  aneurysms  5  mm  or  larger
but  only  57%  and  35%,  respectively,  for  aneurysms  <  5  mm
[46].  Thus,  conventional  angiography  remains  the  gold
standard  and  should  be  performed  when  non-invasive
techniques  are  positive  or  negative  with  a  remaining
suspicion.
t
p
t artery (orange arrow), which was conﬁrmed by three-dimensional
maging of actors involved in infective
ndocarditis pathophysiology
chocardiography,  CT  and  MRI  provide  morphological  imag-
ng  without  accurate  information  on  the  activity  of  IE.  This
ack  of  functional  data  is  a  strong  limitation,  especially
hen  the  microbiological  investigations  are  negative  and
n  case  of  negative  or  doubtful  structural  lesions.  More-
ver,  these  morphological  imaging  modalities  are  insensitive
or  very  early  diagnosis  and  accurate  assessment  of  the
esponse  to  antibiotic  therapy  [47]. Hope  comes  from  the
maging  of  actors  involved  in  IE  pathophysiology.  The  vegeta-
ions  are  composed  of  microorganisms,  inﬂammatory  cells,
latelets  and  ﬁbrin.  Currently,  as  there  are  major  difﬁcul-
ies  in  radiolabelling  microorganisms  at  the  site  of  infection,
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Figure 4. Results of echocardiographic studies and 18F-ﬂuorodeoxyglucose positron emission tomography computed tomography (18F-FDG
PET/CT) in a case of suspicion of aortic bioprosthetic valve infective endocarditis. The ﬁrst transoesophageal echocardiography (TEE) (A)
showed a small doubtful thickening around the aortic bioprosthetic annulus (yellow arrow) in a patient with fever and negative blood
cultures. The second TEE (B), performed 8 days later, showed the development of a periprosthetic abscess (yellow arrow). 18F-FDG PET/CT
performed the day after the ﬁrst TEE showed hyperﬁxation around the aortic prosthesis (C). The patient underwent urgent valve surgery,
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shich conﬁrmed the abscess. Of note, colonic hyperﬁxation was s
evealed at the colonoscopy performed thereafter.
ethods  of  conducting  molecular  imaging  of  the  host’s  reac-
ion  have  emerged.  These  methods  aimed  to  detect  the
nﬂammation  and  infection  processes.  Among  them, 18F-
uorodeoxyglucose  (18F-FDG)  PET/CT  is  the  modality  that
as  been  most  studied  recently  in  the  clinical  setting.
8F-FDG  PTE/CT  in  infective  endocarditis
8F-FDG  PET/CT  is  an  imaging  modality  that  allows  mea-
urement  of  metabolic  activity  within  an  organ,  obtained
rom  the  emission  of  positrons  following  disintegration  of
he  injected  radioactive  product.  As  the  majority  of  the
alignant  cells  have  high  glycolytic  activity,  this  technique
s  widely  used  for  the  diagnosis  and  follow-up  of  cancers.
ecently,  it  has  been  used  for  the  identiﬁcation  of  inﬂam-
atory  and  infectious  processes  because  they  also  result
n  signiﬁcant  FDG  uptake  by  the  inﬂammatory  cells.  Thus,
8F-FDG  PET/CT  has  been  used  in  the  detection  of  vascu-
ar  prosthetic  infections  [48,49].  Recently,  numerous  case
eports  and  a  few  preliminary  studies  have  shown  much
romise  for  this  modality  in  the  setting  of  IE.  It  was  reported
n  several  cases  that 18F-FDG  PET/CT  was  able  to  detect
eriprosthetic  valve  abscesses,  while  the  ﬁrst  TTE  and  TEE
tudies  were  normal  or  doubtful  (Fig.  4)  [50—52]. This  situa-
ion  represents  almost  30%  of  cases  [12]. Moreover, 18F-FDG
ET/CT  is  able  to  reveal  the  source  of  infection,  which  can
e  a  neoplasia  (colonic  cancer)  in  some  cases.  However,
or  the  time  being,  the  role  of 18F-FDG  PET/CT  has  been
specially  investigated  in  the  detection  of  peripheral  emboli
nd  the  diagnosis  of  cardiovascular  implantable  electronic
evice  (CIED)  infections  [53].
l
u
C by F-FDG PET/CT (green arrow), which allowed a polyp to be
In a  prospective  study  including  24  patients  with  deﬁnite
E, 18F-FDG  PET/CT  detected  a  clinically  occult  embolism
r  metastatic  infection  in  28%  of  cases  [50]. Three  recent
orks  have  investigated  the  role  of 18F-FDG  PET/CT  in  CIED
nfections  (Table  2).
Bensimhon  et  al.  investigated  the  diagnostic  value  of
8F-FDG  PET/CT.  The  authors  analysed  21  patients  with  sus-
ected  CIED  infection  and  14  controls  free  of  infection.  The
nal  diagnosis  was  obtained  either  from  bacteriological  data
fter  device  culture  or  by  a  6-month  follow-up  according
o  modiﬁed  Duke’s  criteria.  Sensitivity,  speciﬁcity,  PPV  and
PV  were,  respectively,  80%,  100%,  100%  and  84.6%  in  the
atient-based  analysis;  they  were  100%,  100%,  100%  and
00%  for  boxes  but  only  60%,  100%,  100%  and  73%  for  leads.
one  of  the  control  patients  was  positive  for  CIED  uptake
54].
In  another  study,  Ploux  et  al.  tested  the  role  of 18F-FDG
ET/CT  in  the  management  of  suspected  CIED  infections.  By
ncluding  10  patients  with  a  suspected  CIED  infection  with
egative  TEE  signs,  the  authors  showed  that  six  patients  had
n  increased  FDG  uptake.  As  a  result  of  this  ﬁnding,  these
atients  subsequently  underwent  complete  removal  of  the
mplanted  material.  Cultures  of  the  leads  were  positive  in
ll  six  patients,  conﬁrming  involvement  of  the  leads  in  the
nfectious  process.  In  the  other  four  patients,  the  pacing
ystem  was  left  in  place  without  objective  signs  of  active
ead  endocarditis  during  follow-up  [55].
Sarrazin  et  al.  have  made  additional  important  contrib-
tions  regarding  the  utility  of 18F-FDG  PET/CT  for  suspected
IED  infection.  In  a  study  including  66  patients,  they
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Table  2 Diagnostic  value  of 18F-FDG  PET/CT  in  cardiovascular  implantable  electronic  device  infections.
Study  Material  Sensitivity  (%)  Speciﬁcity  (%)
Bensimhon  et  al.
[54]
Pocket  +  leads 80  100
Leads  60  100
Ploux  et  al.  [55]  Leads  100  93
Sarrazin  et  al.  [56]  Pocket  +  leads  89  86
CT: computed tomography; FDG: ﬂuorodeoxyglucose; PET: positron emission tomography.
Table  3  Potential  indications  for  imaging  modalities  other  than  echocardiography  in  infective  endocarditis.
Imaging  modality  Potential  indications
Cerebral  CT  scan In  all  patients  (with  or  without  neurological  symptoms)  at  admission,  to  detect:  cerebral
infarctions;  cerebral  haemorrhages;  infectious  aneurysms
Abdominal  CT  scan  In  patients  with  a  difﬁcult  diagnostic  situation  or  difﬁcult  surgical  decision,  and  in
patients  with  uncontrolled  infection,  to  detect:  visceral  infarctions;  visceral  abscesses;
infectious  aneurysms
Cerebral  MRI  Same  indications  as  cerebral  CT  scan.  MRI  is  preferable  when  available  because  it
provides  better  sensitivity  for  the  detection  of  small  cerebral  infarctions  and
haemorrhages  without  ionizing  radiation  and  injection  of  nephrotoxic  contrast  products
Cerebral  angiography In  patients  with:  cerebral  haemorrhages;  clinical  suspicion  of  infectious  aneurysm  but
negative  CT  or  MR  angiography;  presence  of  infectious  aneurysm  on  CT  scan  or  MR
angiogram
PET/CT  scan  Suspicion  of  prosthetic  valve  or  pacemaker/deﬁbrillator  leads  endocarditis  with  negative
or  doubtful  echocardiography
CT: computed tomography; MR: magnetic resonance; MRI: magnetic resonance imaging; PET: positron emission tomography.
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mconﬁrmed  the  relative  good  sensitivity  (89%)  and  speciﬁcity
(86%)  of 18F-FDG  PET/CT  interpreted  by  a  qualitative  visual
score.  Moreover,  they  provided  evidence  that  inﬂammation
accompanying  acute  pocket  surgery  does  not  result  in  false
positive  imaging,  thus  extending  the  applicability  of  this
technique  to  suspected  early  device  infection.  The  authors
also  demonstrated  the  ability  to  distinguish  deep  pocket
infection,  which  implies  device  infection  and  the  necessity
for  device  extraction,  from  superﬁcial  infection,  which  can
be  treated  with  antibiotics  alone  [56].
Although  the  preliminary  results  of 18F-FDG  PET/CT  in
the  diagnosis  and  the  management  of  IE  are  encouraging,
several  questions  remain.  What  is  its  value  in  native  and
prosthetic  valve  IE?  Is  it  cost-effective?  What  is  the  impact
of  prolonged  prior  antibiotic  therapy?  What  is  the  impact  of
hyperglycaemia?  More  experience,  especially  with  use  of  the
new  ECG-gated  PET/CT,  is  necessary  before  strong  recom-
mendations  can  be  made  regarding  the  use  of  this  technique.
Other  functional  imaging  modalities
Gallium-67-,  indium-111-  and  technecium-99m-HMPAO-
labelled  leucocyte  scintigraphy  is  another  option  for  imaging
the  infection  that  has  been  used  in  clinical  practice  [57—61].
Unlike 18F-FDG  PET/CT,  this  method  is  more  speciﬁc  for
infection  but  is  more  time-consuming  (24  hours)  and  offers
poor  image  quality.  Although  this  modality  showed  good
w
s
g
ierformances  when  vascular  prosthetic  infection  was  sus-
ected  [62], its  value  in  IE  should  be  demonstrated.
Better  knowledge  of  the  host/pathogen  interaction  offers
ew  perspectives  in  the  ﬁeld  of  functional  imaging  of  IE.
ndeed,  by  labelling  other  actors  involved  in  this  unique
nteraction  some  investigators  have  developed  novel  imag-
ng  methods  from  animal  models.
Because  vegetations  are  platelet-ﬁbrin  clots  in  which
latelet  proaggregant  activity  is  enhanced  by  bacterial
olonization,  Rouzet  et  al.  investigated  the  ability  of  radio-
abelled  (Tc-99m)  annexin  V,  to  provide  in  vivo  functional
maging  of  platelet  activation  in  an  animal  endocardi-
is  model  (rabbits  and  rats).  Annexin  V  is  a  ligand  of
hosphatidylserines  exposed  by  activated  platelets  and
poptotic  cells.  This  experimental  study  showed  that  this
echnique  can  provide  functional  imaging  of  vegetations  as
ell  as  embolic  events  [63].
In  a  mouse  model,  Panizzi  et  al.  developed  a  new  method
or  imaging  S.  aureus  IE.  Because  S.  aureus  is  able  to  induce
lood  coagulation  via  staphylocoagulase,  the  investigators
reated  a  ﬂuorescent  prothrombin-based  probe  that  could
e  activated  in  vivo  by  the  enzyme.  When  injected  into
ice  with  IE,  ﬂuorescence  molecular  tomography  combined
ith  CT  revealed  the  presence  of  vegetations  with  a  high
peciﬁcity  and  a  high  signal  over  background.  Moreover,  they
enerated  a  new  prothrombin-based  probe  for  PET-CT  imag-
ng,  which  showed  similar  results.  Finally,  this  innovative
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Figure 5. Imaging perspectives for improvement of the management of infective endocarditis (IE). 2D: two-dimensional; 3D: three-
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Rimensional; CT: computed tomography; MRI: magnetic resonance
chocardiography; TTE: transthoracic echocardiography.
ethod  allowed  visualization  of  the  response  to  the  antibi-
tic  treatment  [64].
onclusions and perspectives
maging  of  IE  remains  a  diagnostic  challenge  because  echo-
ardiography  has  several  limitations,  which  can  impact  on
atient  prognosis.  Novel  imaging  modalities  are  emerging
nd  offer  hope  of  better  management  of  the  disease  and  thus
 reduction  in  mortality.  Some  of  these  methods  provide  a
etter  morphological  evaluation  of  the  intra-  and  extracar-
iac  damage;  others  allow  visualization  of  the  inﬂammation
nd  infection  at  the  molecular  level.  Although  more  stud-
es  are  necessary  to  clearly  deﬁne  the  indications  for  each
ethod,  the  new  modalities  should  be  included  in  the  diag-
ostic  criteria  for  IE.  The  future  in  imaging  of  IE  will  be
ultimodal  (Table  3,  Fig.  5).
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